Table 2.
Summarization of the effect of HMOs on GBS
Donor | Lewis Blood Group | Antibacterial Activity | Anti-biofilm activity |
---|---|---|---|
1 | a+b− | bacteriostatic (THB, THB + 1% glc) | altered morphology |
2 | a−b+ | - | - |
3 | a−b− | bacteriostatic (THB) | decreased biofilm produced |
4 | a−b+ | - | - |
5 | a−b− | - | - |